Christina U Lorentz (Christina Lorentz, C U Lorentz)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 16

Top Topics

Recombinant Human

Pulmonary Embolism

Top Venues

Communications medicine

Research and practice in thrombosis and haemostasis

This page only lists publications with an associated author ORCID identifier.

Publications

Norah G Verbout, Christina U Lorentz, Brandon D Markway, Michael Wallisch, Thomas C Marbury, Enrico Di Cera, Joseph J Shatzel, András Gruber, Erik I Tucker
Safety and tolerability of the protein C activator AB002 in end-stage renal disease patients on hemodialysis: a randomized phase 2 trial. Communications medicine 4 (1) (2024)
Norah G Verbout, Christina U Lorentz, Brandon D Markway, Michael Wallisch, Thomas C Marbury, Enrico Di Cera, Joseph J Shatzel, András Gruber, Erik I Tucker
Safety and tolerability of the protein C activator AB002 in end-stage renal disease patients on hemodialysis: a randomized phase 2 trial. Communications medicine 4 (1) (2024)
Norah G Verbout, Christina U Lorentz, Brandon D Markway, Michael Wallisch, Thomas C Marbury, Enrico Di Cera, Joseph J Shatzel, András Gruber, Erik I Tucker
Safety and tolerability of the protein C activator AB002 in end-stage renal disease patients on hemodialysis: a randomized phase 2 trial. Communications medicine 4 (1) (2024)
Norah G Verbout, Christina U Lorentz, Brandon D Markway, Michael Wallisch, Thomas C Marbury, Enrico Di Cera, Joseph J Shatzel, András Gruber, Erik I Tucker
Safety and tolerability of the protein C activator AB002 in end-stage renal disease patients on hemodialysis: a randomized phase 2 trial. Communications medicine 4 (1) (2024)
Rick Mathews, Naly Setthavongsack, Anh Le-Cook, Andy Kaempf, Jennifer M Loftis, Randall L Woltjer, Christina U Lorentz, Alexey S Revenko, Monica T Hinds, Khanh P Nguyen
Role of platelet count in a murine stasis model of deep vein thrombosis. Platelets 35 (1) (2023)
Rick Mathews, Naly Setthavongsack, Anh Le-Cook, Andy Kaempf, Jennifer M Loftis, Randall L Woltjer, Christina U Lorentz, Alexey S Revenko, Monica T Hinds, Khanh P Nguyen
Role of platelet count in a murine stasis model of deep vein thrombosis. Platelets 35 (1) (2023)
Rick Mathews, Naly Setthavongsack, Anh Le-Cook, Andy Kaempf, Jennifer M Loftis, Randall L Woltjer, Christina U Lorentz, Alexey S Revenko, Monica T Hinds, Khanh P Nguyen
Role of platelet count in a murine stasis model of deep vein thrombosis. Platelets 35 (1) (2023)
Michael A Pfeffer, Tia C L Kohs, Helen H Vu, Kelley R Jordan, Si-Han Wang, Christina U Lorentz, Erik I Tucker, Cristina Puy, Sven R Olson, Thomas G DeLoughery, Monica T Hinds, Ravi S Keshari, David Gailani, Florea Lupu, Owen J T McCarty, Joseph J Shatzel
Factor XI Inhibition for the Prevention of Catheter-Associated Thrombosis in Patients With Cancer Undergoing Central Line Placement: A Phase 2 Clinical Trial. Arteriosclerosis, thrombosis, and vascular biology (2023)
Rick Mathews, Naly Setthavongsack, Anh Le-Cook, Andy Kaempf, Jennifer M Loftis, Randall L Woltjer, Christina U Lorentz, Alexey S Revenko, Monica T Hinds, Khanh P Nguyen
Role of platelet count in a murine stasis model of deep vein thrombosis. Platelets 35 (1) (2023)
Rick Mathews, Naly Setthavongsack, Anh Le-Cook, Andy Kaempf, Jennifer M Loftis, Randall L Woltjer, Christina U Lorentz, Alexey S Revenko, Monica T Hinds, Khanh P Nguyen
Role of platelet count in a murine stasis model of deep vein thrombosis. Platelets 35 (1) (2023)
Christina U Lorentz, Erik I Tucker, Norah G Verbout, Joseph J Shatzel, Sven R Olson, Brandon D Markway, Michael Wallisch, Martina Ralle, Monica T Hinds, Owen J T McCarty, David Gailani, Jeffrey I Weitz, András Gruber
The contact activation inhibitor AB023 in heparin-free hemodialysis: results of a randomized phase 2 clinical trial. Blood 138 (22) (2022)
Kelley R Jordan, Cory R Wyatt, Meghan E Fallon, Randall L Woltjer, Edward A Neuwelt, Quifang Cheng, David Gailani, Christina U Lorentz, Erik I Tucker, Owen J T McCarty, Monica T Hinds, Khanh P Nguyen
Pharmacological reduction of coagulation factor XI reduces macrophage accumulation and accelerates deep vein thrombosis resolution in a mouse model of venous thrombosis. Journal of thrombosis and haemostasis : JTH 20 (9) (2022)
Cristina Puy, Jiaqing Pang, Stéphanie E Reitsma, Christina U Lorentz, Erik I Tucker, David Gailani, András Gruber, Florea Lupu, Owen J T McCarty
Cross-Talk between the Complement Pathway and the Contact Activation System of Coagulation: Activated Factor XI Neutralizes Complement Factor H. Journal of immunology (Baltimore, Md. : 1950) 206 (8) (2021)
Robert Silasi-Mansat, Ravi Shankar Keshari, Girija Regmi, Cristina Lupu, Constantin Georgescu, Joe H Simmons, Michael Wallisch, Tia C L Kohs, Joseph J Shatzel, Sven R Olson, Christina U Lorentz, Cristina Puy, Erik I Tucker, David Gailani, Sidney Strickland, András Gruber, Owen J T McCarty, Florea Lupu
Factor XII plays a pathogenic role in organ failure and death in baboons challenged with Staphylococcus aureus. Blood 138 (2) (2021)
Tia C L Kohs, Christina U Lorentz, J Johnson, C Puy, S R Olson, J J Shatzel, David Gailani, Monica T Hinds, E I Tucker, András Gruber, Owen J T McCarty, Michael Wallisch
Development of Coagulation Factor XII Antibodies for Inhibiting Vascular Device-Related Thrombosis. Cellular and molecular bioengineering 14 (2) (2020)
Michael Wallisch, Christina U Lorentz, Hari Hara Sudhan Lakshmanan, Jennifer Johnson, Marschelle R Carris, Cristina Puy, David Gailani, Monica T Hinds, Owen J T McCarty, András Gruber, Erik I Tucker
Antibody inhibition of contact factor XII reduces platelet deposition in a model of extracorporeal membrane oxygenator perfusion in nonhuman primates. Research and practice in thrombosis and haemostasis 4 (2) (2020)